ArticleMolecular therapy : the journal of the American Society of Gene Therapy2008

Erythroid-specific human factor IX delivery from in vivo selected hematopoietic stem cells following nonmyeloablative conditioning in hemophilia B mice.

Alex H Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.